actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein (Massachusetts General Hospital)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameactA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein (Massachusetts General Hospital)
Drug Alias NameBMB72 vaccine (Massachusetts General Hospital)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccine +[4
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A